Efficacy and Safety of an Inhaled Anti-TSLP Antibody Fragment in Adults with Mild Atopic Asthma

被引：0

作者：

Gauvreau, G. M. ^{[1
]}

Hohlfeld, J. M. ^{[2
]}

Grant, S. ^{[3
]}

Jain, M. ^{[4
]}

Cabanski, M. ^{[4
]}

Pertel, P. ^{[4
]}

Boulet, L. ^{[5
]}

Cockcroft, D. W. ^{[6
]}

Davis, B. ^{[6
]}

Fitzgerald, J. M. ^{[7
]}

Korn, S. ^{[8
]}

Kornmann, O. ^{[9
]}

Leigh, R. ^{[10
]}

Mayers, I. ^{[11
]}

Watz, H. ^{[12
]}

Lecot, J. ^{[13
]}

O'Byrne, P. ^{[1
]}

机构：

[1] McMaster Univ, Med, Hamilton, ON, Canada

[2] Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany

[3] Novartis, NIBR, Cambridge, MA USA

[4] Novartis, Novartis Inst Biomed Res, Cambridge, MA USA

[5] Laval Univ, Inst Univ Cardiol & Pneumol Quebec, Laval, PQ, Canada

[6] Univ Saskatchewan, Med, Saskatoon, SK, Canada

[7] Univ British Columbia, Gordon & Leslie Diamond Hlth Care Ctr, Vancouver, BC, Canada

[8] Johannes Gutenberg Univ Mainz, Mainz, Germany

[9] Inst Clin Res, Frankfurt, Germany

[10] Univ Calgary, Med, Calgary, AB, Canada

[11] Univ Alberta, Edmonton, AB, Canada

[12] Pulm Res Inst, Grosshansdorf, Germany

[13] Medstat Ltd, Ipswich, Suffolk, England

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A4207

引用

页数：2

共 50 条

[1] The Sputum Transcriptome of Mild Atopic Asthma Following Bronchoprovocation and Inhaled Anti-TSLP Antibody Fragment Treatment
Cabanski, M.
Xu, H.
Zhao, X.
Fernandez, A.
Khokhlovich, E.
Rowlands, M.
Schuhmann, I.
Grant, S. S.
Pertel, P.
Gauvreau, G. M.
O'Byrne, P.
Hohlfeld, J. M.
Vitaliti, A.
Obeidat, M.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
[2] Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma
Gauvreau, Gail M.
Hohlfeld, Jens M.
FitzGerald, J. Mark
Boulet, Louis-Philippe
Cockcroft, Donald W.
Davis, Beth E.
Korn, Stephanie
Kornmann, Oliver
Leigh, Richard
Mayers, Irvin
Watz, Henrik
Grant, Sarah S.
Jain, Monish
Cabanski, Maciej
Pertel, Peter E.
Jones, Ieuan
Lecot, Jean R.
Cao, Hui
O'Byrne, Paul M.
[J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (03)
[3] Development of an inhaled anti-TSLP therapy for asthma
O'Byrne, Paul M.
Panettieri Jr, Reynold A.
Taube, Christian
Brindicci, Caterina
Fleming, Margaret
Altman, Pablo
[J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 78
[4] Anti-TSLP antibody demonstrated to be effective as treatment for asthma
Wilkinson, Jonathan
[J]. IMMUNOTHERAPY, 2014, 6 (07) : 808 - 809
[5] Current summary of clinical studies on anti-TSLP antibody, Tezepelumab, in asthma
Kurihara, Momoko
Kabata, Hiroki
Irie, Misato
Fukunaga, Koichi
[J]. ALLERGOLOGY INTERNATIONAL, 2023, 72 (01) : 24 - 30
[6] Moving Upstream - Anti-TSLP in Persistent Uncontrolled Asthma
Bel, Elisabeth H.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (10): : 989 - 991
[7] Short-term immunological effects of anti-TSLP antibody in patients with severe asthma
Barbet, K.
Haasler, I.
Funke, F.
Schmitz, M. S.
Luengen, A.
Taube, C.
Reuter, S.
[J]. ALLERGOLOGIE, 2024, 47 (02)
[8] Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
Wang, Xiaomu
Kong, Yong
Qiu, Tianquan
Chen, Tao
Liu, Yuzhi
Shi, Gaoyong
Sun, Qiuping
Chen, Wei
Zhang, Juan
Qiu, Jiwan
[J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 142
[9] Affinity improvement of the fully human anti-TSLP recombinant antibody
Chen, Qi
Xian, Dequn
Xu, Wenfeng
Nian, Siji
Yu, Hong
Wu, Yuchuan
Yuan, Qing
[J]. MOLECULAR MEDICINE REPORTS, 2020, 21 (02) : 759 - 767
[10] Tezepelumab Anti-TSLP (thymic stromal lymphopoietin) Treatment of severe asthma
Yao, Y.
Ali, Z.
Thomsen, S. F.
[J]. DRUGS OF THE FUTURE, 2021, 46 (07) : 529 - 536

← 1 2 3 4 5 →